Market Outlook

By 2035, the U.S. Surgical Robotics Market is expected to reach approximately USD 22.75 billion, expanding at a CAGR of 11.30% during the forecast period 2026–2035. The market is estimated at USD 7.80 billion in 2025, compared with approximately USD 6.96 billion in 2024. Historical market values are estimated at approximately USD 5.06 billion in 2021, USD 5.63 billion in 2022, USD 6.25 billion in 2023, and USD 6.96 billion in 2024. Values in this report are expressed in USD billions. The model covers surgical robotic systems, robotic-specific instruments and accessories, procedure-linked consumables, software functionality, maintenance, technical support, and related services, while excluding conventional implants and operating-room equipment that would be purchased irrespective of robotic utilization.

The U.S. represents the deepest and most commercially developed surgical robotics ecosystem globally. The market has progressed beyond early concentration in robotic prostatectomy and gynecologic surgery into a multispecialty capital-equipment and recurring-consumables industry spanning general surgery, colorectal surgery, urology, orthopedics, gynecology, thoracic surgery, bariatric surgery, spine, neurosurgery, microsurgery, and selected specialty procedures. Intuitive reported approximately 6,364 da Vinci systems installed in the United States at year-end 2025, compared with a global installed base of 11,106. The company placed 987 da Vinci systems in the U.S. during 2025 alone, while U.S. da Vinci procedure volumes increased approximately 15% and U.S. general surgery procedures increased approximately 18%.

The next phase of the market will be characterized less by the simple question of whether hospitals should adopt robotics and more by how many platforms a health system should operate, which specialties justify dedicated robotics, how systems should be financed, what utilization level supports an acceptable return on invested capital, and whether competing platforms can reduce procedural cost without compromising clinical performance. This is changing the basis of competition. Hospitals increasingly evaluate robotics as an enterprise surgical infrastructure decision involving surgeon recruitment, OR capacity, patient referral capture, instrument cost, service contracts, training requirements, procedure conversion, capital budgeting, and long-term platform dependence.

The revenue profile also makes surgical robotics structurally different from conventional capital equipment. System placement is only the beginning of the economic relationship. Robotic-specific instruments, accessories, software, service, maintenance, and procedure-dependent consumables generate recurring revenue throughout the installed life of a platform. Intuitive’s 2025 global economics illustrate the model: da Vinci systems generally sold for approximately USD 0.7 million to USD 3.1 million depending on configuration, instruments and accessories generated roughly USD 900 to USD 3,700 per procedure, and annual service arrangements typically ranged from about USD 95,000 to USD 225,000.

Under the current market model, U.S. surgical robotics revenue is projected to move from approximately USD 8.68 billion in 2026 to USD 13.32 billion in 2030 and USD 22.75 billion in 2035. Growth will increasingly come from a combination of higher system utilization, next-generation system replacement, competitive soft-tissue platform launches, expansion of robotic general surgery, penetration of robotics into orthopedic and spine workflows, increased adoption by ambulatory facilities, specialty robots for microsurgery and urologic treatment, and rising recurring revenue per installed platform.

 

Introduction

According to the U.S. Surgical Robotics Market Report, robotic-assisted surgery has evolved into an important component of U.S. hospital surgical strategy rather than a stand-alone premium technology. The country combines high surgical procedure volumes, sophisticated hospital infrastructure, specialist density, established minimally invasive surgery practices, significant capital budgets, a large commercially insured population, substantial Medicare procedure volume, and an innovation ecosystem capable of supporting clinical trials, surgeon training, device iteration, and rapid commercialization.

The addressable provider infrastructure is substantial. American Hospital Association statistics identify more than 6,000 hospitals across the United States, including more than 5,100 community hospitals. Robotics is concentrated within acute-care hospitals, academic centers, tertiary referral facilities, large community hospitals, orthopedic institutions, cancer centers, and increasingly ambulatory surgery centers. Large health systems can operate dozens or even hundreds of robotic platforms across their networks. HCA Healthcare reported approximately 934 robots across roughly 20 robotic platform types as of March 2025 and stated that its facilities had surpassed one million robotic procedures.

Disease burden also provides a durable procedure foundation. The American Cancer Society estimated approximately 2.04 million new cancer diagnoses in the United States during 2025, maintaining a large surgical oncology pool across prostate, colorectal, kidney, lung, gynecologic and other cancers for which minimally invasive robotic approaches may be used when clinically appropriate. At the same time, an aging population is sustaining demand for joint replacement, spinal procedures, benign prostatic hyperplasia treatment and other surgeries where robotics can improve planning, instrumentation control, bone preparation or soft-tissue manipulation.

The market should not be interpreted as one homogeneous robotic category. Soft-tissue platforms such as da Vinci, Hugo, Versius, OTTAVA and emerging modular systems compete around visualization, instrument articulation, ergonomics, OR integration, digital data and procedure breadth. Orthopedic platforms compete around surgical planning, implant positioning, bone preparation, balancing and implant ecosystem integration. Spine and neurosurgical systems compete around navigation accuracy and trajectory execution. Specialty robotic platforms are emerging for microsurgery, waterjet prostate tissue resection, miniaturized abdominal surgery and other targeted applications.

This diversification is strategically important because it reduces dependence on any single clinical specialty. Surgical robotics increasingly functions as a collection of procedure-specific technology ecosystems linked by common hospital procurement requirements: clinical evidence, dependable service, surgeon acceptance, staff training, procedure throughput, capital affordability, instrument availability, cybersecurity, interoperability and measurable economic benefit.

 

Key Market Drivers: What’s Fueling the U.S. Surgical Robotics Market Boom?

The first major market driver is the continuing conversion of conventional minimally invasive and open procedures toward robotic-assisted workflows. Robotic utilization is no longer driven principally by prostatectomy. General surgery has become a major volume engine, particularly cholecystectomy, inguinal and ventral hernia repair, appendectomy, colorectal surgery and other abdominal procedures. Intuitive reported approximately 18% growth in U.S. general surgery procedures during 2025, with cholecystectomy, hernia repair and appendectomy contributing significant incremental volume. This is strategically important because these procedures exist across a much larger number of community hospitals than highly specialized oncologic surgery.

A second driver is the expanding installed base and the resulting compounding effect of recurring procedural revenue. Once a hospital has trained surgeons and operating-room teams on a platform, incremental utilization can generate instruments, accessories and service revenue without requiring a new system sale. Higher utilization therefore expands the market even in years when capital placement growth moderates. At year-end 2025, Intuitive’s U.S. da Vinci base exceeded 6,300 systems, demonstrating the depth of domestic infrastructure already available for further procedure conversion.

The third driver is the entry of credible alternative soft-tissue robotic platforms. Historically, hospitals considering broad soft-tissue robotics faced limited platform choice. That competitive structure is changing. CMR Surgical’s Versius received U.S. De Novo authorization in 2024, Distalmotion’s Dexter also received U.S. authorization in 2024, Medtronic’s Hugo received FDA clearance for urologic surgical procedures in December 2025, and Johnson & Johnson received U.S. FDA market authorization for OTTAVA in July 2026. Greater platform competition should expand hospital evaluation activity, encourage alternative financing and service models, and accelerate innovation around footprint, flexibility, instrumentation and total procedural economics.

The fourth driver is the rapid adoption of robotics in orthopedics. Robotic-assisted knee and hip replacement has moved from an early-adopter technology into a strategic implant-enablement platform for major orthopedic manufacturers. Stryker’s Mako ecosystem has now supported millions of procedures globally, while Zimmer Biomet’s ROSA, Smith+Nephew’s CORI, Johnson & Johnson MedTech’s VELYS and THINK Surgical’s TMINI create a broad competitive field. Stryker reported more than 2.5 million Mako procedures globally through 2025, underscoring the scale that orthopedic robotics has achieved. For suppliers, the economic value of orthopedic robotics extends beyond robot revenue because the platform can support implant pull-through, surgeon loyalty and long-term account retention.

A fifth driver is hospital competition for surgeons and patients. Robotics has become an element of service-line positioning. Health systems operating in competitive metropolitan markets use advanced robotic programs to recruit surgeons, retain complex cases, expand minimally invasive surgery programs and support patient acquisition. A hospital may therefore approve a robotic investment even when the financial case is not based entirely on direct robotic-system revenue. The full economic analysis can include inpatient-to-outpatient migration, reduced length of stay where clinically demonstrated, increased operating-room utilization, downstream imaging and rehabilitation revenue, specialist recruitment and competitive protection of high-value surgical service lines.

The sixth driver is a gradual shift toward ambulatory and lower-acuity care settings. Traditional multiarm systems were developed primarily around hospital operating rooms, but compact, modular, handheld and smaller-footprint systems are lowering infrastructure barriers. Ambulatory surgery centers typically require faster room turnover, lower capital intensity, simplified setup and predictable per-procedure economics. Systems designed specifically around those constraints can address facilities that would not support the economics of large traditional platforms. This is particularly important in orthopedics, hernia repair, selected gynecology, urology and other procedures already migrating toward outpatient care.

A seventh driver is specialty robotics. PROCEPT BioRobotics represents a commercially meaningful example of a procedure-specific robotic franchise. At the end of 2025, the company reported approximately 718 AquaBeam and HYDROS robotic systems installed in the United States, demonstrating that focused robotic technologies can build substantial installed bases outside conventional multi-specialty laparoscopy. Similar specialization is emerging in microsurgery, miniaturized abdominal surgery, spine, neurosurgery and other fields.

Finally, reimbursement and hospital capital allocation remain essential determinants of adoption. There is generally no universal reimbursement premium simply because a surgeon uses a robot. Hospitals must therefore create economic value from procedure volume, workflow efficiency, market share, clinical outcomes, shorter recovery where supported by evidence, reduced complications, service-line differentiation, or favorable site-of-care migration. This requirement increasingly favors platforms capable of demonstrating utilization rather than simply technical sophistication.

 

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in the U.S. surgical robotics market is moving from mechanical assistance toward digitally instrumented surgery. Future platforms are being designed to generate information before, during and after procedures rather than simply translating a surgeon’s hand movements. Artificial intelligence, force sensing, computer vision, advanced imaging, instrument tracking, procedure analytics and automated workflow measurement are becoming differentiating features.

Intuitive’s da Vinci 5, which received FDA clearance in March 2024, illustrates this transition. The fifth-generation platform incorporates substantially greater computing capacity, redesigned ergonomics and force-sensing capabilities intended to provide richer procedural data and enhance surgical performance. The strategic value of these capabilities lies partly in creating a future software and analytics layer around a large installed surgical infrastructure.

Modularity represents another important innovation direction. Rather than requiring a fixed multiarm configuration for every case, emerging systems are allowing hospitals to configure robotic components based on procedure and operating-room requirements. CMR Surgical’s Versius architecture and Medtronic’s Hugo platform reflect this movement toward modularity and greater flexibility. Johnson & Johnson’s OTTAVA takes a different approach through table-integrated robotic architecture. These competing designs indicate that the next decade will involve multiple interpretations of what the optimal robotic operating room should look like.

Miniaturization is also expanding the addressable market. Virtual Incision’s MIRA received FDA De Novo authorization in February 2024 as a table-mounted miniaturized electromechanical surgical system. Moon Surgical’s Maestro received FDA clearances supporting its commercial U.S. development, while Distalmotion is targeting flexible robotic workflows including outpatient surgery. Smaller systems can potentially reduce footprint, simplify setup and make robotic assistance economically feasible for facilities unable to support conventional large-platform utilization.

Microsurgery represents another frontier. Medical Microinstruments received FDA De Novo authorization for its Symani Surgical System in April 2024 for specified microsurgical soft-tissue manipulation. The technology is designed for extremely small vessels and lymphatic structures where motion scaling and precision are particularly valuable. The commercial opportunity is smaller than mainstream abdominal or orthopedic robotics today, but it demonstrates how robotics can expand into surgical tasks where human dexterity becomes a limiting factor.

Orthopedic robotics is becoming increasingly software-driven. Platforms are advancing from basic alignment assistance toward personalized planning, ligament balancing, intraoperative assessment, revision applications and broader multi-joint capabilities. Zimmer Biomet obtained FDA clearance for ROSA Knee with OptimiZe in late 2025, adding personalized surgical planning and enhanced tracking functionality. Stryker is similarly extending Mako beyond primary hip and knee replacement into revision, spine and other applications.

The longer-term innovation pathway points toward increasing levels of automation, although fully autonomous surgery remains substantially different from today’s surgeon-controlled systems. Near-term commercial value is more likely to come from bounded automation: automated camera positioning, constrained cutting, real-time safety boundaries, instrument recognition, objective performance measurement, automatic workflow documentation, intelligent surgical planning and decision support. Manufacturers that can deploy these capabilities without creating unacceptable regulatory, liability or workflow complexity will strengthen their competitive position.

 

Segmentation Insights

The U.S. Surgical Robotics Market is segmented on the basis of offering, surgical application, robotic platform type, end user, and region.

 

By Offering

Robotic Systems

Robotic systems represent the capital foundation of the market and account for an estimated 38% of 2025 market revenue, or approximately USD 2.96 billion under the report’s market definition. This category includes surgeon consoles, robotic arms, patient-side systems, control hardware, visualization architecture and robotic planning equipment. Growth is supported by new installations, replacement cycles, trade-ins, competitive platform launches and expansion into community hospitals and outpatient settings.

The economics of this category are changing as suppliers use operating leases, usage-based arrangements, subscription structures and strategic system placements to reduce initial capital barriers. Over time, the number of systems installed may grow faster than recognized up-front system revenue as flexible financing becomes more common.

Instruments, Accessories and Procedure-Linked Consumables

Instruments, accessories and consumables form the largest offering segment, representing an estimated 44% of the 2025 market. Products include robotic graspers, scissors, stapling instruments, energy instruments, needle drivers, drapes, cannulas, specialized cutting accessories, procedure kits and other products whose consumption rises with robotic case volume.

This category is strategically attractive because it converts an installed capital base into recurring revenue. Instruments can also create substantial switching friction. Once surgeons are trained and procedural preferences have been built around a particular platform, hospitals must consider not only the cost of changing robots but the implications for instrumentation, staff workflow and clinical training.

Services, Software and Support

Services, maintenance, digital functionality and software represent approximately 18% of the market and are expected to become increasingly important through 2035. Robotic platforms require preventive maintenance, technical service, software updates, clinical support, surgeon training and uptime guarantees. Premium analytics, procedure-data tools and software-enabled functions may gradually increase revenue per installed system.

 

By Surgical Application

General Surgery

General surgery is estimated to be the largest application segment in 2025, supported by cholecystectomy, hernia repair, colorectal surgery, appendectomy and other abdominal procedures. The significance of this segment comes from the breadth of potential users. These procedures occur in academic hospitals, community facilities and increasingly outpatient environments, creating a larger addressable provider base than highly specialized robotic oncology alone.

Urologic Surgery

Urology remains one of the most mature robotic specialties. Robotic prostatectomy established much of the original clinical infrastructure for soft-tissue surgical robotics in the United States. Today the category also includes partial nephrectomy, cystectomy, pyeloplasty and specialty robotic treatment of benign prostatic hyperplasia. The presence of both multispecialty surgical robots and dedicated platforms such as AquaBeam/HYDROS creates a diverse competitive environment.

Orthopedic Surgery

Orthopedics is one of the strongest growth opportunities through 2035. Robotic total knee, partial knee and total hip procedures are increasingly supported by large implant manufacturers, while spine and shoulder applications broaden the opportunity. Orthopedic robotics is commercially distinctive because platform placement may influence implant selection, allowing manufacturers to evaluate robotics as an account-retention and implant-share strategy rather than as an isolated capital business.

Gynecologic Surgery

Gynecology remains an established robotic application across hysterectomy, myomectomy, endometriosis surgery, oncologic procedures and selected pelvic reconstruction. Growth is expected to be steadier than in early adoption years, although new platform competition and expanding community access should continue to support volume.

Colorectal, Thoracic and Bariatric Surgery

These procedures constitute important premium robotic applications where articulation, visualization and access in confined anatomy can support surgeon preference. Thoracic surgery is relevant for selected lung and mediastinal procedures, while colorectal surgery remains an important complex general-surgery category. Bariatric robotic utilization is more sensitive to procedure trends and health-system economics but remains strategically relevant to multispecialty platforms.

Spine, Neurosurgery, Microsurgery and Other Applications

Spine and neurosurgical robotics rely heavily on image guidance, navigation and trajectory execution rather than the soft-tissue telemanipulation model used by abdominal robots. Microsurgery adds motion scaling and tremor reduction for very small anatomical structures. These segments are smaller in revenue today but have potential to produce above-market growth because robotic penetration remains substantially lower.

 

By Robotic Platform Type

Soft-Tissue Multiport Systems

Soft-tissue multiport systems represent the largest platform category. They are used across general surgery, urology, gynecology, colorectal, thoracic and other procedures and benefit from established surgeon training infrastructure. The principal strategic trend is increasing competition around instrumentation breadth, visualization, ergonomics, digital capabilities and lifetime procedural economics.

Modular, Compact and Miniaturized Soft-Tissue Systems

This is expected to be one of the fastest-growing platform categories through 2035. Modular and compact architectures are designed to improve operating-room flexibility and make robotics accessible to smaller hospitals and ambulatory facilities. Versius, Dexter, MIRA, Maestro and related concepts illustrate the shift toward differentiated form factors.

Orthopedic Robotic Systems

Orthopedic platforms include robotic-arm, handheld and digitally guided systems used in joint reconstruction and related procedures. Mako, ROSA, CORI, VELYS and TMINI are prominent platforms. Competition increasingly centers on planning flexibility, implant compatibility, CT requirements, operating-room footprint, workflow speed and breadth of indications.

Spine and Neurosurgical Robotics

This segment includes robotic guidance and navigation platforms supporting spinal instrumentation, stereotactic procedures and other precision interventions. Growth will be linked to navigation integration, imaging interoperability and the ability to reduce workflow complexity in technically demanding procedures.

Microsurgery and Specialty Procedure Robots

Microsurgical robots, robotic waterjet systems and other purpose-built platforms represent an emerging category. Rather than attempting to become universal surgical systems, these technologies address discrete clinical workflows where automation or precision can create an identifiable procedural benefit. Specialty robotics should contribute disproportionately to market innovation over the forecast period.

 

By End User

Hospitals and Integrated Health Systems

Hospitals and integrated delivery networks account for approximately 80% of 2025 U.S. surgical robotics revenue. They possess the procedure volume, capital resources, operating-room infrastructure and multispecialty staff needed to support large robotic programs. Major IDNs increasingly evaluate robotics at enterprise scale, which can lead to multi-system contracts, standardized instrumentation, network-wide training programs and strategic vendor relationships.

For these buyers, the procurement question is increasingly portfolio-based. A network may use one platform for broad soft-tissue surgery, another for orthopedics and additional specialty robots for spine or urologic treatment. Vendor success therefore depends on both clinical differentiation and the ability to integrate with health-system capital planning.

Academic Medical Centers and Specialty Surgical Hospitals

Academic hospitals and specialty institutions remain critical early adopters. They participate in clinical studies, train robotic surgeons, evaluate emerging platforms and develop new procedural applications. Their influence on commercialization is substantially greater than their numerical share of U.S. facilities because physician training and clinical evidence generated at major centers can shape downstream community adoption.

Ambulatory Surgery Centers

ASCs are expected to record the fastest end-user growth through 2035. Orthopedics, hernia repair and selected urologic and gynecologic procedures are particularly relevant. ASC purchasing requirements differ from hospital requirements: smaller footprint, lower capital burden, simplified turnover and clearly defined per-procedure economics matter considerably more. Compact systems and flexible financing models should therefore gain disproportionate attention in this segment.

Other Surgical Facilities

Other users include specialty clinics and facilities operating highly focused robotic programs. Their current revenue contribution is limited but may rise as smaller systems and procedure-specific robots remove infrastructure barriers.

 

Regional Insights: Where the Market is Growing Fastest

The U.S. market is segmented into the South, Northeast, West and Midwest. The South is estimated to represent the largest regional market in 2025, while the West is projected to achieve the fastest growth through 2035. Regional performance is shaped by hospital concentration, population growth, surgeon density, orthopedic procedure volumes, academic medical centers, capital availability, private-insurance penetration, Medicare exposure and competitive health-system investment.

Regional analysis is especially important in surgical robotics because the U.S. market does not develop uniformly. Robotic adoption is shaped by local health-system competition and capital availability rather than population alone. A metropolitan area with multiple competing tertiary hospitals can support substantially higher robotic-system density than a larger but more dispersed population. State-level opportunity therefore depends on the number of major surgical programs, health-system consolidation, surgeon recruitment competition, outpatient infrastructure and replacement requirements of existing robotic fleets.

South

The South represents the largest regional U.S. Surgical Robotics Market, estimated at approximately USD 2.75 billion in 2025. Based on regional procedure growth, population expansion, health-system investment and new-platform penetration, the market is projected to approach USD 8.09 billion by 2035, representing an estimated regional CAGR of approximately 11.4%.

The region comprises Texas, Florida, Georgia, North Carolina, South Carolina, Virginia, Maryland, Delaware, West Virginia, Kentucky, Tennessee, Alabama, Mississippi, Arkansas, Louisiana, Oklahoma and the District of Columbia. Its market leadership is supported by large and rapidly growing metropolitan populations, substantial orthopedic and general-surgery demand, expanding hospital networks and intense competition among major health systems.

Texas is one of the most strategically important state markets nationally. Houston, Dallas-Fort Worth, Austin and San Antonio contain large tertiary hospitals, academic programs, cancer centers and multispecialty surgical networks. Texas also provides strong evidence of replacement-cycle investment. Texas Health Resources initially adopted da Vinci 5 at facilities in Dallas and Fort Worth and subsequently announced plans to place the technology at 10 additional hospitals across its network. This type of network deployment illustrates how next-generation platforms can move from individual hospital purchases toward system-level fleet upgrades.

Florida represents another major robotic surgery market because of its large population, significant Medicare exposure, extensive hospital infrastructure and high orthopedic, urologic and general-surgery demand. During 2025, multiple Florida health systems announced new da Vinci 5 investments. Ascension Florida, for example, announced deployment across five hospitals, while Tallahassee Memorial and other systems also expanded next-generation robotic capacity. Florida should remain highly attractive for both soft-tissue and orthopedic robotic suppliers because the state combines mature robotic adoption with continuing population growth.

North Carolina, Georgia, Tennessee and Virginia provide a second tier of large and expanding opportunities. Charlotte, Raleigh-Durham, Atlanta, Nashville, Richmond and Northern Virginia contain strong surgical referral centers and integrated health systems. North Carolina also benefits from a substantial medtech and clinical-research environment, while Tennessee contains large health-system operators with influence extending beyond state boundaries.

Maryland and the District of Columbia have smaller populations but disproportionately sophisticated medical infrastructure, including major academic and federal institutions. Kentucky, Alabama, Louisiana, Oklahoma, Arkansas, Mississippi and West Virginia represent smaller state markets but offer opportunities for community-level penetration as compact systems and alternative financing lower the minimum case volume required to justify robotics.

Over the forecast period, the South should remain the largest regional revenue pool because it combines existing hospital robotics infrastructure with strong demographic expansion. The most important commercial opportunity will increasingly be fleet expansion and procedure conversion within existing accounts, rather than first-time robotic adoption alone.

West

The West accounted for an estimated USD 1.80 billion in 2025 and is projected to reach approximately USD 5.85 billion by 2035, representing an estimated 12.5% CAGR, the fastest among the four regions.

The region includes California, Washington, Oregon, Nevada, Arizona, Utah, Colorado, New Mexico, Idaho, Montana, Wyoming, Alaska and Hawaii. Its growth profile is driven by advanced academic medical centers, medtech innovation, technology-friendly provider organizations, population expansion in several Southwestern and Mountain states, and strong adoption of digital surgery.

California is the dominant state market in the West and one of the largest surgical robotics markets nationally. The state combines a very large surgical population with academic institutions, integrated delivery networks, cancer centers, major private systems and proximity to a substantial share of the surgical-robotics innovation ecosystem. Intuitive itself is headquartered in California, while several emerging robotics companies and technology developers also maintain operations in the state.

California hospitals continue to invest in next-generation systems rather than relying exclusively on legacy fleets. MemorialCare announced deployment of da Vinci 5 across Orange Coast Medical Center, Saddleback Medical Center and Long Beach Medical Center during 2025. Such deployments indicate that replacement and standardization cycles may become as important as new robotic-program creation in mature metropolitan markets.

Arizona and Nevada should generate above-average growth due to population expansion, growing retiree populations and continued hospital construction and ambulatory development. Arizona is additionally relevant to outpatient robotic treatment; PROCEPT’s WATER IV prostate cancer study included robotic Aquablation procedures in a Scottsdale ambulatory surgery center in 2025, highlighting the potential migration of specialized robotics beyond hospitals.

Washington, Oregon and Colorado are sophisticated adoption markets with integrated health systems that tend to emphasize clinical evidence, digital connectivity and system-level standardization. Utah combines population growth with strong tertiary surgical programs, while Idaho, Montana, Wyoming, Alaska and Hawaii have smaller absolute market sizes but may benefit from robotics that allows regional hospitals to retain procedures otherwise referred to major metropolitan centers.

The West is likely to gain modest national share through 2035 because its hospital systems are well positioned to adopt AI-enabled surgical analytics, next-generation orthopedics, compact robotics and digital operating-room infrastructure. The region is also strategically valuable for early commercialization because technology adoption at influential West Coast providers can support broader national market visibility.

Northeast

The Northeast represented an estimated USD 1.86 billion in 2025 and is projected to reach approximately USD 5.09 billion by 2035, reflecting an estimated CAGR of roughly 10.6%.

The region includes New York, Pennsylvania, New Jersey, Massachusetts, Connecticut, Rhode Island, Maine, New Hampshire and Vermont. Compared with the South and West, population growth is slower, but surgical robotics intensity is supported by the concentration of major academic medical centers, cancer institutes, teaching hospitals and specialist surgeons.

New York represents the largest state opportunity in the Northeast. New York City alone supports multiple competing academic and tertiary surgical systems, while upstate health systems provide additional robotic procedure volumes. UR Medicine, for example, introduced da Vinci 5 into its Rochester-area program in 2025, illustrating ongoing next-generation adoption outside New York City.

Massachusetts is commercially influential beyond its population size because Boston contains a dense network of academic hospitals, biomedical research institutions and advanced surgical programs. New technologies often gain clinical evaluation and key-opinion-leader exposure in this environment before broader community adoption.

Pennsylvania represents another significant market across Philadelphia, Pittsburgh and regional health systems. The state also played an early role in the commercialization of robotic microsurgery: the first U.S. cases with MMI’s Symani platform following authorization were completed at Penn Medicine in 2024. This illustrates the Northeast’s importance for specialty robotics and clinical evidence generation.

New Jersey and Connecticut benefit from dense populations, affluent commercial insurance markets and proximity to major academic referral ecosystems. Rhode Island, Maine, New Hampshire and Vermont are smaller markets, where robotic investments are more likely to be concentrated in large regional referral centers rather than broadly distributed among community facilities.

Northeast procurement tends to be evidence-intensive. Mature academic hospitals often require a higher standard of clinical differentiation because conventional minimally invasive surgery is already highly developed. Consequently, new entrants may find these institutions difficult to penetrate commercially but extremely valuable for clinical validation and surgeon advocacy.

Midwest

The Midwest accounted for an estimated USD 1.39 billion in 2025 and is projected to reach approximately USD 3.74 billion by 2035, representing an estimated CAGR of approximately 10.4%.

The region includes Illinois, Ohio, Michigan, Indiana, Wisconsin, Minnesota, Iowa, Missouri, Kansas, Nebraska, North Dakota and South Dakota. The Midwest offers a stable combination of mature hospital infrastructure, large orthopedic procedure volumes, major academic centers and extensive regional health systems.

Illinois is led by the Chicago metropolitan healthcare market, which contains academic, nonprofit, for-profit and specialty institutions supporting broad robotic utilization. Ohio has major surgical referral centers and strong orthopedic, cardiovascular, urologic and cancer programs. Michigan provides a substantial community and academic hospital base, while Minnesota has particular strategic importance because of its longstanding medical-device ecosystem and sophisticated health systems.

Iowa offers an example of how robotics is diffusing into regional academic systems. University of Iowa Health Care added three da Vinci 5 systems in 2025 and estimated that the additional capacity could support approximately 1,000 more robotic-assisted procedures each year. This represents an important market dynamic: in established programs, the investment case can be based on eliminating capacity constraints rather than creating demand from zero.

Indiana, Wisconsin and Missouri offer meaningful orthopedic and general-surgery demand across metropolitan and regional hospital networks. Kansas, Nebraska, North Dakota and South Dakota are smaller markets where capital affordability, service availability and surgeon concentration can constrain broad adoption. Nevertheless, compact and specialty robotic systems may allow selected regional facilities to add capabilities without replicating the infrastructure of a major academic center.

The Midwest is expected to grow somewhat more slowly than the South and West but should remain a durable robotics market. Manufacturers that provide dependable field service, flexible contracting, surgeon training and demonstrable cost-per-case economics are particularly well positioned in the region.

 

Key Market Players

The U.S. Surgical Robotics Competitive Landscape is transitioning from a market characterized by one dominant soft-tissue platform toward a more complex ecosystem of established leaders, orthopedic robotics companies, new soft-tissue entrants and procedure-specific innovators.

Intuitive Surgical remains the benchmark competitor in multispecialty soft-tissue robotics because of its U.S. installed base, extensive instruments portfolio, clinical familiarity, surgeon-training infrastructure and large recurring-revenue stream. Stryker maintains a leading position in orthopedic robotics through Mako, while Zimmer Biomet, Smith+Nephew and Johnson & Johnson MedTech compete strongly around robotics-enabled orthopedic reconstruction.

The soft-tissue competitive environment has changed significantly with Medtronic’s Hugo, CMR Surgical’s Versius, Distalmotion’s Dexter and Johnson & Johnson’s OTTAVA. These platforms create credible alternatives for hospital procurement committees that historically had fewer choices when evaluating broad abdominal robotic surgery.

Specialty competitors add another dimension. PROCEPT BioRobotics has built a meaningful urologic robotic franchise around Aquablation. MMI is commercializing robotic microsurgery. Virtual Incision and Moon Surgical are developing compact robotic approaches. THINK Surgical competes in orthopedic robotics. Globus Medical participates in robotic spine and navigation, while Brainlab and other navigation specialists contribute to the broader digitally guided surgery ecosystem.

Some of the key companies relevant to the U.S. Surgical Robotics Market include Intuitive Surgical, Stryker Corporation, Medtronic, Johnson & Johnson MedTech, Zimmer Biomet, Smith+Nephew, Globus Medical, CMR Surgical, Distalmotion, Virtual Incision, Medical Microinstruments (MMI), Moon Surgical, THINK Surgical, PROCEPT BioRobotics, Brainlab, Accuray, KARL STORZ/Asensus Surgical, Renishaw, Vicarious Surgical, EndoQuest Robotics, SS Innovations International, Monogram Technologies/Zimmer Biomet, Siemens Healthineers/Corindus and other emerging digital-surgery developers.

Competitive advantage through 2035 will increasingly depend on lifetime economics rather than system specifications alone. Vendors must demonstrate how effectively a hospital can turn an installed platform into sustainable case volume. High utilization lowers capital cost per procedure, improves staff proficiency and strengthens recurring economics. Poor utilization has the opposite effect and can make even technologically advanced systems financially unattractive.

The winning platform strategy will therefore combine clinical capabilities with surgeon training, high system uptime, instrumentation depth, flexible financing, credible clinical evidence, rapid technical support, software development and health-economic data. Vendors capable of working at IDN level rather than selling one robot at a time will have an additional advantage as U.S. hospital consolidation continues.

 

Recent Developments

The U.S. surgical robotics competitive environment has changed materially since 2024.

In March 2024, Intuitive received U.S. FDA clearance for da Vinci 5, initiating a major fifth-generation replacement and expansion cycle within the country’s largest existing soft-tissue robotic installed base.

In February 2024, Virtual Incision’s MIRA Surgical System received FDA De Novo authorization, strengthening the commercial case for miniaturized robotic systems capable of operating with a substantially different footprint from traditional platforms.

In April 2024, Medical Microinstruments received U.S. authorization to commercialize the Symani Surgical System, establishing a new robotic category around microsurgical soft-tissue manipulation.

In October 2024, CMR Surgical received FDA De Novo marketing authorization for the Versius Surgical System, introducing a modular soft-tissue robotic competitor into the U.S. market. Distalmotion also received U.S. authorization for its Dexter platform during October 2024, adding another differentiated entrant focused on flexible robotic surgery workflows.

During 2025, hospitals accelerated acquisition of next-generation systems. Intuitive placed 987 da Vinci systems in the United States, compared with 800 during 2024, demonstrating strong capital demand despite the already substantial installed base.

In December 2025, Medtronic received U.S. FDA clearance for the Hugo robotic-assisted surgery system for urologic surgical procedures. The authorization introduced a major global medtech competitor into the U.S. soft-tissue robotics market and strengthened the likelihood of increased competition around system contracting, instrumentation and operating-room integration.

CMR Surgical also received FDA 510(k) clearance for Versius Plus in December 2025, preparing the company for expanded U.S. commercialization of its next-generation system.

Orthopedic robotics also continued to advance. Zimmer Biomet obtained U.S. clearance for ROSA Knee with OptimiZe in November 2025, while Stryker broadened the Mako ecosystem through additional applications and next-generation platform development.

The competitive landscape changed again in July 2026, when the FDA granted De Novo market authorization to Johnson & Johnson’s OTTAVA Robotic Surgical System for multiple upper-abdominal general-surgery procedures. The entry of Johnson & Johnson is particularly important because the company can connect robotics with a broad existing surgical-instrument and energy portfolio.

These developments mark a structural transition in U.S. surgical robotics. The market is moving from a relatively concentrated first generation toward a multi-platform environment in which hospitals will increasingly compare robotic architectures, purchasing models and procedural economics across vendors.

 

Conclusion

The U.S. Surgical Robotics Market Size & Share is positioned for significant expansion from approximately USD 7.80 billion in 2025 to USD 22.75 billion by 2035, representing a CAGR of approximately 11.30% during 2026–2035. Historical expansion from approximately USD 5.06 billion in 2021 to USD 6.96 billion in 2024 reflects both post-pandemic surgical normalization and the broadening of robotics beyond early urologic and gynecologic applications.

The market’s investment case is stronger than a conventional capital-equipment forecast because revenue compounds through three mechanisms. The first is growth in the number of installed robotic systems. The second is increased procedure utilization per installed system. The third is recurring revenue from instruments, accessories, procedure-specific consumables, software and service. Together these mechanisms create an increasingly durable installed-base business model.

General surgery will remain one of the most important procedure-volume engines, while orthopedic robotics is expected to contribute disproportionately to incremental growth. Urology will remain strategically important because of its mature robotic penetration and continued emergence of specialized technologies such as Aquablation. Spine, neurosurgery, microsurgery and miniaturized soft-tissue robotics provide longer-term whitespace.

From a procurement perspective, the decisive market variable will increasingly be robotic utilization economics. Hospitals do not benefit merely from owning the newest platform. They benefit when the technology supports adequate case volume, surgeon retention, OR throughput, patient access, appropriate site-of-care migration and clinically defensible outcomes. As a result, system uptime, training, procedure breadth, consumable economics and service quality will increasingly influence purchasing alongside technical performance.

Regionally, the South is expected to remain the largest market, supported by Texas, Florida, Georgia, North Carolina, Tennessee and Virginia. The West should record the fastest growth, led by California and high-growth states such as Arizona, Nevada, Colorado and Utah. The Northeast will remain a high-value innovation and academic adoption market, while the Midwest will provide a stable procedure base with substantial orthopedic and health-system demand.

For surgical robotics manufacturers, investors, hospitals, distributors and strategic buyers evaluating the period through 2035, the central opportunity is no longer simply greater robotic penetration. The larger opportunity is the creation of a multi-platform, procedure-dense, digitally connected robotic surgery ecosystem in which hardware placement drives recurring instruments, software, service, analytics and clinical workflow revenue.

The U.S. market is therefore entering a more competitive and commercially sophisticated phase. Intuitive’s installed-base advantage remains substantial, but Medtronic, Johnson & Johnson, CMR Surgical, Distalmotion and other entrants are expanding choice in soft-tissue robotics. Stryker, Zimmer Biomet, Smith+Nephew, Johnson & Johnson and THINK Surgical are accelerating competition in orthopedics, while specialty players are opening new robotic categories.

By 2035, leadership will belong less to the company offering the most visually impressive robot and more to the company that can demonstrate repeatable clinical utility, scalable procedural adoption, favorable lifetime economics, strong recurring revenue, dependable hospital integration and a credible pathway from surgical data to measurable improvement in care delivery.

 

TABLE OF CONTENT

1. U.S. Surgical Robotics Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Analytical Frameworks & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Surgical Robotic System Manufacturers
1.6.2. Robotic Instruments, Accessories and Component Suppliers
1.6.3. Software, AI, Imaging and Surgical Navigation Providers
1.6.4. Hospitals and Integrated Delivery Networks
1.6.5. Academic Medical Centers and Specialty Surgical Hospitals
1.6.6. Ambulatory Surgery Centers
1.6.7. Surgeons, Clinical Training Centers and Key Opinion Leaders
1.6.8. Group Purchasing Organizations and Procurement Committees
1.6.9. Payers, Regulators and Clinical Decision-Makers

What this section provides: This section defines the U.S. surgical robotics market boundary, revenue scope, methodology, assumptions, stakeholder structure, and validation framework so clients understand how robotic systems, recurring instruments, software, services, and procedure-linked revenues are measured.

2. U.S. Surgical Robotics Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. U.S. Surgical Robotics Installed Base Overview
2.8. Robotic-Assisted Procedure Volume Outlook
2.9. Capital Equipment vs. Recurring Revenue Economics
2.10. High-Growth Opportunity Areas
2.11. Key Investment and Commercialization Themes

What this section provides: This section gives decision-makers a concise view of U.S. market size, historical development, forecast growth, installed robotic infrastructure, procedure utilization, recurring revenue economics, competitive intensity, and high-priority opportunities.

3. U.S. Surgical Robotics Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Rising Adoption of Robotic-Assisted Minimally Invasive Surgery
3.1.2. Expansion of Robotic General Surgery Procedure Volumes
3.1.3. Growth of Orthopedic Robotic-Assisted Surgery
3.1.4. Increasing Installed Base of Surgical Robotic Platforms
3.1.5. Next-Generation Robotic System Replacement Cycles
3.1.6. Growing Hospital Competition for Advanced Surgical Programs
3.1.7. Expansion of Robotics into Ambulatory Surgery Centers
3.1.8. Growth of Procedure-Specific and Specialty Surgical Robots
3.1.9. Rising Recurring Instruments, Accessories and Service Revenue
3.2. Restraints and Their Impact Analysis
3.2.1. High Initial Capital Acquisition Cost
3.2.2. Robotic Instrument and Consumable Cost per Procedure
3.2.3. Absence of Universal Robotic-Specific Reimbursement Premium
3.2.4. Long Learning Curves and Surgeon Training Requirements
3.2.5. Operating Room Setup and Workflow Complexity
3.2.6. Low Utilization Risk in Smaller Hospitals
3.2.7. Long Capital Replacement and Budget Approval Cycles
3.3. Opportunities and Their Impact Analysis
3.3.1. Multi-Platform Soft-Tissue Robotics Competition
3.3.2. Robotic General Surgery Conversion
3.3.3. Orthopedic and Joint Replacement Robotics
3.3.4. Spine and Neurosurgical Robotics
3.3.5. Microsurgery and Specialty Robotic Procedures
3.3.6. Compact and Miniaturized Surgical Robotic Systems
3.3.7. ASC-Focused Robotic Platforms
3.3.8. AI-Enabled Surgical Data and Procedure Analytics
3.3.9. Robotic Platform Leasing and Usage-Based Commercial Models
3.4. Challenges and Their Impact Analysis
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Robotic Procedure Workflow Economics Analysis
3.7. Hospital Capital Procurement Behavior Analysis
3.8. Surgeon Training and Credentialing Landscape
3.9. Installed Base Utilization and Capacity Analysis
3.10. Robotic Procedure Conversion Potential Analysis

What this section provides: This section explains the clinical, economic, technological, reimbursement, capital procurement, and utilization forces determining surgical robotic adoption and helps clients assess both market upside and commercialization barriers.

4. U.S. Surgical Robotics Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Hospital and IDN Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk from Conventional Laparoscopic and Open Surgery
4.2.5. Competitive Rivalry
4.3. Surgical Robotic System Pricing Trend Analysis, 2025–2035
4.4. Robotic Instruments and Accessories Pricing Analysis
4.5. Service Contract and Maintenance Economics
4.6. Value Chain & Supply Chain Analysis
4.7. Surgical Robotics Component Supply Landscape
4.8. Impact of AI, Computer Vision and Digital Surgery
4.9. Application & Innovation Landscape
4.10. FDA Regulatory Framework Analysis
4.11. CMS Reimbursement and Coverage Landscape
4.12. Hospital Capital Budgeting Environment
4.13. Import/Export Restrictions & Tariff Impact
4.14. Cybersecurity and Connected Surgical Platform Requirements
4.15. Impact of Escalating Geopolitical and Supply Chain Tensions
4.16. Hospital Value Analysis Committee Decision Framework
4.17. Robotic Platform Switching Costs and Vendor Lock-In Analysis

What this section provides: This section provides a comprehensive assessment of regulation, reimbursement, pricing, supply chain, digitalization, hospital purchasing criteria, switching costs, and competitive forces influencing U.S. surgical robotics.

5. U.S. Surgical Robotics Market – By Offering

5.1. Overview
5.1.1. Segment Share Analysis, By Offering, 2025 & 2035 (%)
5.1.2. Robotic Systems
5.1.2.1. Surgeon Consoles
5.1.2.2. Patient-Side Robotic Units
5.1.2.3. Robotic Arms and Manipulators
5.1.2.4. Visualization and Control Systems
5.1.2.5. Robotic Surgical Planning Hardware
5.1.3. Instruments & Accessories
5.1.3.1. Robotic Graspers and Forceps
5.1.3.2. Robotic Scissors
5.1.3.3. Needle Drivers
5.1.3.4. Stapling Instruments
5.1.3.5. Energy Instruments
5.1.3.6. Cannulas and Trocars
5.1.3.7. Robotic Drapes and Procedure Accessories
5.1.3.8. Orthopedic Robotic Cutting and Preparation Accessories
5.1.3.9. Other Procedure-Specific Robotic Consumables
5.1.4. Software & Digital Solutions
5.1.4.1. Surgical Planning Software
5.1.4.2. AI-Assisted Surgical Software
5.1.4.3. Computer Vision and Image Guidance
5.1.4.4. Procedure Analytics and Performance Intelligence
5.1.4.5. Remote Monitoring and Fleet Management Software
5.1.5. Services & Support
5.1.5.1. Maintenance and Service Contracts
5.1.5.2. Technical Support
5.1.5.3. Surgeon Training and Education
5.1.5.4. OR Workflow and Implementation Services
5.1.5.5. Software Upgrade and Platform Support Services

What this section provides: This section determines how U.S. surgical robotics revenue is distributed across capital systems, recurring instruments and accessories, software, and service revenues and identifies which offering categories will generate the strongest value growth through 2035.

6. U.S. Surgical Robotics Market – By Surgical Application

6.1. Overview
6.1.1. Segment Share Analysis, By Surgical Application, 2025 & 2035 (%)
6.1.2. General Surgery
6.1.2.1. Cholecystectomy
6.1.2.2. Inguinal Hernia Repair
6.1.2.3. Ventral and Incisional Hernia Repair
6.1.2.4. Appendectomy
6.1.2.5. Foregut Surgery
6.1.2.6. Other General Surgical Procedures
6.1.3. Urologic Surgery
6.1.3.1. Radical Prostatectomy
6.1.3.2. Partial and Radical Nephrectomy
6.1.3.3. Cystectomy
6.1.3.4. Pyeloplasty
6.1.3.5. Benign Prostatic Hyperplasia Procedures
6.1.3.6. Other Urologic Procedures
6.1.4. Gynecologic Surgery
6.1.4.1. Hysterectomy
6.1.4.2. Myomectomy
6.1.4.3. Endometriosis Surgery
6.1.4.4. Gynecologic Oncology
6.1.4.5. Pelvic Reconstructive Surgery
6.1.5. Orthopedic Surgery
6.1.5.1. Total Knee Arthroplasty
6.1.5.2. Partial Knee Arthroplasty
6.1.5.3. Total Hip Arthroplasty
6.1.5.4. Revision Joint Replacement
6.1.5.5. Shoulder and Emerging Orthopedic Procedures
6.1.6. Colorectal Surgery
6.1.6.1. Colectomy
6.1.6.2. Rectal Resection
6.1.6.3. Other Colorectal Procedures
6.1.7. Thoracic Surgery
6.1.7.1. Lobectomy
6.1.7.2. Mediastinal Procedures
6.1.7.3. Other Thoracic Procedures
6.1.8. Bariatric Surgery
6.1.8.1. Sleeve Gastrectomy
6.1.8.2. Gastric Bypass
6.1.8.3. Revisional Bariatric Surgery
6.1.9. Spine Surgery
6.1.9.1. Spinal Fusion
6.1.9.2. Pedicle Screw Placement
6.1.9.3. Other Robotic-Guided Spine Procedures
6.1.10. Neurosurgery
6.1.11. Microsurgery
6.1.12. Other Specialty Surgical Applications

What this section provides: This section identifies the surgical specialties and procedure categories contributing the largest robotic procedure volumes, fastest conversion rates, and strongest revenue opportunities through 2035.

7. U.S. Surgical Robotics Market – By Robotic Platform Type

7.1. Overview
7.1.1. Segment Share Analysis, By Robotic Platform Type, 2025 & 2035 (%)
7.1.2. Soft-Tissue Multiport Robotic Systems
7.1.2.1. Integrated Multi-Arm Systems
7.1.2.2. Modular Multi-Arm Systems
7.1.3. Single-Port and Miniaturized Soft-Tissue Robotic Systems
7.1.3.1. Single-Port Robotic Platforms
7.1.3.2. Table-Mounted Miniaturized Systems
7.1.3.3. Compact Robotic Assistance Platforms
7.1.4. Orthopedic Robotic Systems
7.1.4.1. Robotic-Arm Assisted Systems
7.1.4.2. Handheld Robotic Systems
7.1.4.3. Image-Based Orthopedic Robotics
7.1.4.4. Imageless Orthopedic Robotics
7.1.5. Spine and Neurosurgical Robotic Systems
7.1.5.1. Robotic Spine Guidance Systems
7.1.5.2. Stereotactic and Cranial Robotic Systems
7.1.6. Microsurgery Robotic Systems
7.1.7. Specialty Procedure-Specific Robotic Systems
7.1.7.1. Robotic Waterjet Surgical Systems
7.1.7.2. Image-Guided Interventional Robotic Systems
7.1.7.3. Other Specialty Platforms

What this section provides: This section evaluates the competing robotic architectures shaping U.S. adoption and compares opportunities across traditional multiport systems, modular platforms, compact robots, orthopedic robotics, spine systems, microsurgery, and specialty robotic technologies.

8. U.S. Surgical Robotics Market – By End User

8.1. Overview
8.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
8.1.2. Hospitals and Integrated Health Systems
8.1.2.1. Large Integrated Delivery Networks
8.1.2.2. Tertiary and Quaternary Hospitals
8.1.2.3. Community Hospitals
8.1.3. Academic Medical Centers
8.1.4. Specialty Surgical Hospitals
8.1.4.1. Orthopedic Specialty Hospitals
8.1.4.2. Cancer Centers
8.1.4.3. Urology and Specialty Surgical Centers
8.1.5. Ambulatory Surgery Centers
8.1.5.1. Hospital-Owned ASCs
8.1.5.2. Physician-Owned ASCs
8.1.5.3. Corporate Multi-Site ASC Networks
8.1.6. Other Surgical Facilities

What this section provides: This section explains which U.S. provider settings are driving robotic system purchases, fleet expansion, procedure utilization, replacement cycles, and future penetration, with specific attention to the growing ASC opportunity.

9. U.S. Surgical Robotics Market: Procedure Economics, Procurement & Commercialization Analysis

9.1. Overview
9.2. Surgical Robotic System Capital Cost Analysis
9.3. Instruments and Accessories Cost per Procedure
9.4. Annual Service and Maintenance Cost Analysis
9.5. Total Cost of Ownership Analysis
9.6. Cost per Robotic Procedure Analysis
9.7. Break-Even Procedure Volume Analysis
9.8. Installed Base Utilization Analysis
9.9. OR Setup, Turnover and Workflow Economics
9.10. Surgeon Training Cost and Learning Curve Economics
9.11. Robotic Platform Replacement Cycle Analysis
9.12. Direct Capital Purchase Model
9.13. Operating Lease Model
9.14. Usage-Based and Per-Procedure Commercial Models
9.15. Enterprise IDN Contracting
9.16. Group Purchasing Organization Influence
9.17. Robotic Platform Standardization Across Health Systems
9.18. Multi-Vendor vs. Single-Vendor Robotic Fleet Strategy
9.19. Hospital Value Analysis Committee Evaluation Criteria
9.20. ASC Robotic Surgery Business Case
9.21. Recurring Revenue and Installed-Base Monetization Analysis
9.22. Vendor Switching Costs and Platform Lock-In
9.23. Surgeon Recruitment and Referral Capture Economics
9.24. Robotic Surgery ROI Framework

What this section provides: This section translates surgical robotics into hospital economics by examining acquisition cost, utilization requirements, procedure cost, service expense, financing structures, contracting models, recurring revenue, and return-on-investment considerations.

10. U.S. Surgical Robotics Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Surgical Robotic Installed Base Analysis
10.1.4. Regional Robotic-Assisted Procedure Volume Analysis
10.1.5. Regional Hospital and ASC Infrastructure Analysis
10.1.6. Regional Capital Procurement and Replacement Cycle Analysis
10.1.7. Regional Competitive Intensity and Platform Adoption Analysis
10.2. West Region
10.2.1. Regional Overview & Trends
10.2.2. West Region Key Surgical Robotics Manufacturers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Offering, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Surgical Application, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By Robotic Platform Type, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.8. West Region Robotic Installed Base, Procedure Volume and Procurement Analysis
10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Offering, 2021–2035
10.2.9.3. California Market Size and Forecast, By Surgical Application, 2021–2035
10.2.9.4. California Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.2.9.5. California Market Size and Forecast, By End User, 2021–2035
10.2.9.6. California Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Offering, 2021–2035
10.2.10.3. Washington Market Size and Forecast, By Surgical Application, 2021–2035
10.2.10.4. Washington Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.2.10.5. Washington Market Size and Forecast, By End User, 2021–2035
10.2.10.6. Washington Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Offering, 2021–2035
10.2.11.3. Arizona Market Size and Forecast, By Surgical Application, 2021–2035
10.2.11.4. Arizona Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.2.11.5. Arizona Market Size and Forecast, By End User, 2021–2035
10.2.11.6. Arizona Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Offering, 2021–2035
10.2.12.3. Colorado Market Size and Forecast, By Surgical Application, 2021–2035
10.2.12.4. Colorado Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.2.12.5. Colorado Market Size and Forecast, By End User, 2021–2035
10.2.12.6. Colorado Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Offering, 2021–2035
10.2.13.3. Oregon Market Size and Forecast, By Surgical Application, 2021–2035
10.2.13.4. Oregon Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.2.13.5. Oregon Market Size and Forecast, By End User, 2021–2035
10.2.13.6. Oregon Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Offering, 2021–2035
10.2.14.3. Utah Market Size and Forecast, By Surgical Application, 2021–2035
10.2.14.4. Utah Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.2.14.5. Utah Market Size and Forecast, By End User, 2021–2035
10.2.14.6. Utah Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Offering, 2021–2035
10.2.15.3. Nevada Market Size and Forecast, By Surgical Application, 2021–2035
10.2.15.4. Nevada Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.2.15.5. Nevada Market Size and Forecast, By End User, 2021–2035
10.2.15.6. Nevada Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Offering, 2021–2035
10.2.16.3. New Mexico Market Size and Forecast, By Surgical Application, 2021–2035
10.2.16.4. New Mexico Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.2.16.5. New Mexico Market Size and Forecast, By End User, 2021–2035
10.2.16.6. New Mexico Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Offering, 2021–2035
10.2.17.3. Idaho Market Size and Forecast, By Surgical Application, 2021–2035
10.2.17.4. Idaho Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.2.17.5. Idaho Market Size and Forecast, By End User, 2021–2035
10.2.17.6. Idaho Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Offering, 2021–2035
10.2.18.3. Montana Market Size and Forecast, By Surgical Application, 2021–2035
10.2.18.4. Montana Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.2.18.5. Montana Market Size and Forecast, By End User, 2021–2035
10.2.18.6. Montana Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Offering, 2021–2035
10.2.19.3. Wyoming Market Size and Forecast, By Surgical Application, 2021–2035
10.2.19.4. Wyoming Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.2.19.5. Wyoming Market Size and Forecast, By End User, 2021–2035
10.2.19.6. Wyoming Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Offering, 2021–2035
10.2.20.3. Alaska Market Size and Forecast, By Surgical Application, 2021–2035
10.2.20.4. Alaska Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.2.20.5. Alaska Market Size and Forecast, By End User, 2021–2035
10.2.20.6. Alaska Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Offering, 2021–2035
10.2.21.3. Hawaii Market Size and Forecast, By Surgical Application, 2021–2035
10.2.21.4. Hawaii Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.2.21.5. Hawaii Market Size and Forecast, By End User, 2021–2035
10.2.21.6. Hawaii Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.3. Northeast Region
10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Key Surgical Robotics Manufacturers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035
10.3.4. Northeast Region Market Size and Forecast, By Offering, 2021–2035
10.3.5. Northeast Region Market Size and Forecast, By Surgical Application, 2021–2035
10.3.6. Northeast Region Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.3.7. Northeast Region Market Size and Forecast, By End User, 2021–2035
10.3.8. Northeast Region Robotic Installed Base, Procedure Volume and Procurement Analysis
10.3.9. New York
10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Offering, 2021–2035
10.3.9.3. New York Market Size and Forecast, By Surgical Application, 2021–2035
10.3.9.4. New York Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.3.9.5. New York Market Size and Forecast, By End User, 2021–2035
10.3.9.6. New York Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Offering, 2021–2035
10.3.10.3. Massachusetts Market Size and Forecast, By Surgical Application, 2021–2035
10.3.10.4. Massachusetts Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.3.10.5. Massachusetts Market Size and Forecast, By End User, 2021–2035
10.3.10.6. Massachusetts Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Offering, 2021–2035
10.3.11.3. New Jersey Market Size and Forecast, By Surgical Application, 2021–2035
10.3.11.4. New Jersey Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.3.11.5. New Jersey Market Size and Forecast, By End User, 2021–2035
10.3.11.6. New Jersey Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Offering, 2021–2035
10.3.12.3. Pennsylvania Market Size and Forecast, By Surgical Application, 2021–2035
10.3.12.4. Pennsylvania Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.3.12.5. Pennsylvania Market Size and Forecast, By End User, 2021–2035
10.3.12.6. Pennsylvania Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Offering, 2021–2035
10.3.13.3. Connecticut Market Size and Forecast, By Surgical Application, 2021–2035
10.3.13.4. Connecticut Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.3.13.5. Connecticut Market Size and Forecast, By End User, 2021–2035
10.3.13.6. Connecticut Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Offering, 2021–2035
10.3.14.3. Maine Market Size and Forecast, By Surgical Application, 2021–2035
10.3.14.4. Maine Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.3.14.5. Maine Market Size and Forecast, By End User, 2021–2035
10.3.14.6. Maine Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Offering, 2021–2035
10.3.15.3. Vermont Market Size and Forecast, By Surgical Application, 2021–2035
10.3.15.4. Vermont Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.3.15.5. Vermont Market Size and Forecast, By End User, 2021–2035
10.3.15.6. Vermont Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Offering, 2021–2035
10.3.16.3. New Hampshire Market Size and Forecast, By Surgical Application, 2021–2035
10.3.16.4. New Hampshire Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.3.16.5. New Hampshire Market Size and Forecast, By End User, 2021–2035
10.3.16.6. New Hampshire Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Offering, 2021–2035
10.3.17.3. Rhode Island Market Size and Forecast, By Surgical Application, 2021–2035
10.3.17.4. Rhode Island Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.3.17.5. Rhode Island Market Size and Forecast, By End User, 2021–2035
10.3.17.6. Rhode Island Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.3.18. Delaware
10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Offering, 2021–2035
10.3.18.3. Delaware Market Size and Forecast, By Surgical Application, 2021–2035
10.3.18.4. Delaware Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.3.18.5. Delaware Market Size and Forecast, By End User, 2021–2035
10.3.18.6. Delaware Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.4. South Region
10.4.1. Regional Overview & Trends
10.4.2. South Region Key Surgical Robotics Manufacturers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035
10.4.4. South Region Market Size and Forecast, By Offering, 2021–2035
10.4.5. South Region Market Size and Forecast, By Surgical Application, 2021–2035
10.4.6. South Region Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.4.7. South Region Market Size and Forecast, By End User, 2021–2035
10.4.8. South Region Robotic Installed Base, Procedure Volume and Procurement Analysis
10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Offering, 2021–2035
10.4.9.3. Texas Market Size and Forecast, By Surgical Application, 2021–2035
10.4.9.4. Texas Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.4.9.5. Texas Market Size and Forecast, By End User, 2021–2035
10.4.9.6. Texas Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Offering, 2021–2035
10.4.10.3. Florida Market Size and Forecast, By Surgical Application, 2021–2035
10.4.10.4. Florida Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.4.10.5. Florida Market Size and Forecast, By End User, 2021–2035
10.4.10.6. Florida Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Offering, 2021–2035
10.4.11.3. Georgia Market Size and Forecast, By Surgical Application, 2021–2035
10.4.11.4. Georgia Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.4.11.5. Georgia Market Size and Forecast, By End User, 2021–2035
10.4.11.6. Georgia Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Offering, 2021–2035
10.4.12.3. North Carolina Market Size and Forecast, By Surgical Application, 2021–2035
10.4.12.4. North Carolina Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.4.12.5. North Carolina Market Size and Forecast, By End User, 2021–2035
10.4.12.6. North Carolina Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Offering, 2021–2035
10.4.13.3. Tennessee Market Size and Forecast, By Surgical Application, 2021–2035
10.4.13.4. Tennessee Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.4.13.5. Tennessee Market Size and Forecast, By End User, 2021–2035
10.4.13.6. Tennessee Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Offering, 2021–2035
10.4.14.3. South Carolina Market Size and Forecast, By Surgical Application, 2021–2035
10.4.14.4. South Carolina Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.4.14.5. South Carolina Market Size and Forecast, By End User, 2021–2035
10.4.14.6. South Carolina Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Offering, 2021–2035
10.4.15.3. Alabama Market Size and Forecast, By Surgical Application, 2021–2035
10.4.15.4. Alabama Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.4.15.5. Alabama Market Size and Forecast, By End User, 2021–2035
10.4.15.6. Alabama Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Offering, 2021–2035
10.4.16.3. Mississippi Market Size and Forecast, By Surgical Application, 2021–2035
10.4.16.4. Mississippi Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.4.16.5. Mississippi Market Size and Forecast, By End User, 2021–2035
10.4.16.6. Mississippi Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Offering, 2021–2035
10.4.17.3. Louisiana Market Size and Forecast, By Surgical Application, 2021–2035
10.4.17.4. Louisiana Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.4.17.5. Louisiana Market Size and Forecast, By End User, 2021–2035
10.4.17.6. Louisiana Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Offering, 2021–2035
10.4.18.3. Arkansas Market Size and Forecast, By Surgical Application, 2021–2035
10.4.18.4. Arkansas Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.4.18.5. Arkansas Market Size and Forecast, By End User, 2021–2035
10.4.18.6. Arkansas Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Offering, 2021–2035
10.4.19.3. Kentucky Market Size and Forecast, By Surgical Application, 2021–2035
10.4.19.4. Kentucky Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.4.19.5. Kentucky Market Size and Forecast, By End User, 2021–2035
10.4.19.6. Kentucky Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Offering, 2021–2035
10.4.20.3. Oklahoma Market Size and Forecast, By Surgical Application, 2021–2035
10.4.20.4. Oklahoma Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.4.20.5. Oklahoma Market Size and Forecast, By End User, 2021–2035
10.4.20.6. Oklahoma Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Offering, 2021–2035
10.4.21.3. Virginia Market Size and Forecast, By Surgical Application, 2021–2035
10.4.21.4. Virginia Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.4.21.5. Virginia Market Size and Forecast, By End User, 2021–2035
10.4.21.6. Virginia Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Offering, 2021–2035
10.4.22.3. Maryland Market Size and Forecast, By Surgical Application, 2021–2035
10.4.22.4. Maryland Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.4.22.5. Maryland Market Size and Forecast, By End User, 2021–2035
10.4.22.6. Maryland Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.4.23. West Virginia
10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Offering, 2021–2035
10.4.23.3. West Virginia Market Size and Forecast, By Surgical Application, 2021–2035
10.4.23.4. West Virginia Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.4.23.5. West Virginia Market Size and Forecast, By End User, 2021–2035
10.4.23.6. West Virginia Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.5. Midwest Region
10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Key Surgical Robotics Manufacturers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035
10.5.4. Midwest Region Market Size and Forecast, By Offering, 2021–2035
10.5.5. Midwest Region Market Size and Forecast, By Surgical Application, 2021–2035
10.5.6. Midwest Region Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.5.7. Midwest Region Market Size and Forecast, By End User, 2021–2035
10.5.8. Midwest Region Robotic Installed Base, Procedure Volume and Procurement Analysis
10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Offering, 2021–2035
10.5.9.3. Illinois Market Size and Forecast, By Surgical Application, 2021–2035
10.5.9.4. Illinois Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.5.9.5. Illinois Market Size and Forecast, By End User, 2021–2035
10.5.9.6. Illinois Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Offering, 2021–2035
10.5.10.3. Ohio Market Size and Forecast, By Surgical Application, 2021–2035
10.5.10.4. Ohio Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.5.10.5. Ohio Market Size and Forecast, By End User, 2021–2035
10.5.10.6. Ohio Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Offering, 2021–2035
10.5.11.3. Michigan Market Size and Forecast, By Surgical Application, 2021–2035
10.5.11.4. Michigan Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.5.11.5. Michigan Market Size and Forecast, By End User, 2021–2035
10.5.11.6. Michigan Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Offering, 2021–2035
10.5.12.3. Minnesota Market Size and Forecast, By Surgical Application, 2021–2035
10.5.12.4. Minnesota Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.5.12.5. Minnesota Market Size and Forecast, By End User, 2021–2035
10.5.12.6. Minnesota Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Offering, 2021–2035
10.5.13.3. Indiana Market Size and Forecast, By Surgical Application, 2021–2035
10.5.13.4. Indiana Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.5.13.5. Indiana Market Size and Forecast, By End User, 2021–2035
10.5.13.6. Indiana Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Offering, 2021–2035
10.5.14.3. Wisconsin Market Size and Forecast, By Surgical Application, 2021–2035
10.5.14.4. Wisconsin Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.5.14.5. Wisconsin Market Size and Forecast, By End User, 2021–2035
10.5.14.6. Wisconsin Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Offering, 2021–2035
10.5.15.3. Missouri Market Size and Forecast, By Surgical Application, 2021–2035
10.5.15.4. Missouri Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.5.15.5. Missouri Market Size and Forecast, By End User, 2021–2035
10.5.15.6. Missouri Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Offering, 2021–2035
10.5.16.3. Iowa Market Size and Forecast, By Surgical Application, 2021–2035
10.5.16.4. Iowa Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.5.16.5. Iowa Market Size and Forecast, By End User, 2021–2035
10.5.16.6. Iowa Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Offering, 2021–2035
10.5.17.3. Kansas Market Size and Forecast, By Surgical Application, 2021–2035
10.5.17.4. Kansas Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.5.17.5. Kansas Market Size and Forecast, By End User, 2021–2035
10.5.17.6. Kansas Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Offering, 2021–2035
10.5.18.3. Nebraska Market Size and Forecast, By Surgical Application, 2021–2035
10.5.18.4. Nebraska Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.5.18.5. Nebraska Market Size and Forecast, By End User, 2021–2035
10.5.18.6. Nebraska Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Offering, 2021–2035
10.5.19.3. North Dakota Market Size and Forecast, By Surgical Application, 2021–2035
10.5.19.4. North Dakota Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.5.19.5. North Dakota Market Size and Forecast, By End User, 2021–2035
10.5.19.6. North Dakota Robotic Installed Base, Procedure Volume & Procurement Dynamics
10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Offering, 2021–2035
10.5.20.3. South Dakota Market Size and Forecast, By Surgical Application, 2021–2035
10.5.20.4. South Dakota Market Size and Forecast, By Robotic Platform Type, 2021–2035
10.5.20.5. South Dakota Market Size and Forecast, By End User, 2021–2035
10.5.20.6. South Dakota Robotic Installed Base, Procedure Volume & Procurement Dynamics

What this section provides: This section provides detailed regional and state-level surgical robotics intelligence across all 50 states, enabling clients to identify robotic adoption hotspots, hospital and ASC clusters, procedure-volume opportunities, installed-base expansion potential, replacement-cycle demand, and priority commercial territories.

11. U.S. Surgical Robotics Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Competitive Market Concentration Analysis
11.3. Company Positioning Matrix
11.3.1. Leaders
11.3.2. Challengers
11.3.3. Innovators
11.3.4. Emerging Players
11.4. Platform Benchmarking Analysis
11.4.1. Clinical Application Breadth
11.4.2. Installed Base
11.4.3. System Architecture
11.4.4. Instrument Portfolio
11.4.5. Capital Cost and Commercial Model
11.4.6. Recurring Revenue Model
11.4.7. Surgeon Training Infrastructure
11.4.8. Digital, AI and Data Capabilities
11.5. Company Profiles
11.5.1. Intuitive Surgical
11.5.2. Stryker Corporation
11.5.3. Medtronic
11.5.4. Johnson & Johnson MedTech
11.5.5. Zimmer Biomet
11.5.6. Smith+Nephew
11.5.7. Globus Medical
11.5.8. CMR Surgical
11.5.9. Distalmotion
11.5.10. Virtual Incision
11.5.11. Medical Microinstruments (MMI)
11.5.12. Moon Surgical
11.5.13. THINK Surgical
11.5.14. PROCEPT BioRobotics
11.5.15. Brainlab
11.5.16. Accuray
11.5.17. KARL STORZ / Asensus Surgical
11.5.18. Renishaw
11.5.19. Vicarious Surgical
11.5.20. EndoQuest Robotics
11.5.21. SS Innovations International
11.5.22. Momentis Surgical
11.5.23. Quantum Surgical
11.5.24. Microbot Medical
11.5.25. Levita Magnetics
11.6. Competitive Strategy Analysis
11.7. Mergers, Acquisitions and Strategic Partnerships
11.8. FDA Clearance and Product Pipeline Benchmarking
11.9. U.S. Commercial Expansion Strategies
11.10. Hospital Contracting and Installed-Base Defense Strategies

Note: Each company profile will include company overview, surgical robotics portfolio, U.S. installed-base positioning where available, clinical applications, financial positioning, regulatory status, commercial strategy, partnerships, innovation pipeline, and recent developments.

What this section provides: This section gives clients competitor benchmarking, market-share visibility, robotic platform positioning, regulatory intelligence, installed-base strategy, product pipeline analysis, and actionable intelligence on leading and emerging surgical robotics companies.

12. U.S. Surgical Robotics Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. Artificial Intelligence-Assisted Surgery
12.2.2. Computer Vision and Real-Time Tissue Recognition
12.2.3. Force and Haptic Feedback
12.2.4. Automated Surgical Workflow Assistance
12.2.5. Semi-Autonomous Surgical Functions
12.2.6. Digital Twin and Personalized Surgical Planning
12.2.7. Advanced Imaging and Navigation Integration
12.2.8. Miniaturized and Portable Surgical Robotics
12.2.9. Cloud-Connected Robotic Surgery Platforms
12.3. Evolution of Multi-Platform Hospital Robotics
12.4. Future Robotic Procedure Penetration
12.5. Surgical Robot Replacement Cycle Outlook
12.6. Future ASC Adoption Potential
12.7. Emerging Business and Commercial Models
12.8. Recurring Revenue Expansion Opportunity
12.9. Business Opportunities for Startups and Existing Players
12.10. Investment Prioritization Matrix
12.11. High-Potential Surgical Specialties, 2026–2035
12.12. Technology White-Space Analysis

What this section provides: This section prepares clients for the next generation of surgical robotics by assessing alternative market scenarios, AI and automation, platform replacement, procedure penetration, ASC adoption, specialty robotics, and high-value investment opportunities through 2035.

13. U.S. Surgical Robotics Market: Strategic Recommendations

13.1. Recommendations for Surgical Robotics Manufacturers
13.2. Recommendations for Hospitals and Integrated Health Systems
13.3. Recommendations for Academic Medical Centers
13.4. Recommendations for Ambulatory Surgery Centers
13.5. Recommendations for Investors and Private Equity Firms
13.6. Recommendations for Distributors and Channel Partners
13.7. Recommendations for New Entrants and Startups
13.8. Go-to-Market Strategy Considerations
13.9. Robotic Platform Pricing and Contracting Strategy
13.10. Surgeon Training and Clinical Adoption Strategy
13.11. Installed-Base Expansion Strategy
13.12. Product Positioning and Portfolio Expansion Guidance
13.13. Hospital IDN Account Penetration Strategy
13.14. ASC Commercialization Strategy
13.15. Strategic Partnership and M&A Opportunity Framework

What this section provides: This section converts the market analysis into actionable recommendations for product strategy, hospital commercialization, installed-base expansion, ASC penetration, contracting, investment decisions, surgeon adoption, and long-term competitive differentiation.

14. U.S. Surgical Robotics Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Forecasting Limitation
14.4. Legal Disclaimer
14.5. Third-Party Data Disclaimer
14.6. Company and Product Information Disclaimer
14.7. Regulatory Status Disclaimer

What this section provides: This section defines the report’s scope limitations, forecasting boundaries, legal conditions, third-party data limitations, company information considerations, and regulatory-status assumptions.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Surgical Robotics Market: Market Definition and Scope
TABLE 3: U.S. Surgical Robotics Market: Research Methodology Framework
TABLE 4: U.S. Surgical Robotics Market: Key Assumptions
TABLE 5: U.S. Surgical Robotics Market: Market Ecosystem Overview
TABLE 6: U.S. Surgical Robotics Market: Stakeholder Analysis
TABLE 7: U.S. Surgical Robotics Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Surgical Robotics Market: Analyst Viewpoint Summary
TABLE 9: U.S. Surgical Robotics Market: Market Attractiveness Index
TABLE 10: U.S. Surgical Robotics Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Surgical Robotics Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 12: U.S. Surgical Robotics Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 13: U.S. Surgical Robotics Market: Installed Base and Robotic Procedure Volume Snapshot, 2025
TABLE 14: U.S. Surgical Robotics Market: High-Growth Opportunity Areas
TABLE 15: U.S. Surgical Robotics Market: Drivers; Impact Analysis
TABLE 16: U.S. Surgical Robotics Market: Restraints; Impact Analysis
TABLE 17: U.S. Surgical Robotics Market: Opportunities; Impact Analysis
TABLE 18: U.S. Surgical Robotics Market: Challenges; Impact Analysis
TABLE 19: U.S. Surgical Robotics Market: Patent & Innovation Analysis, 2021–2025
TABLE 20: U.S. Surgical Robotics Market: Robotic Procedure Workflow Economics Matrix
TABLE 21: U.S. Surgical Robotics Market: Hospital Capital Procurement Behavior Matrix
TABLE 22: U.S. Surgical Robotics Market: Installed Base Utilization and Procedure Conversion Analysis
TABLE 23: U.S. Surgical Robotics Market: PESTEL Analysis
TABLE 24: U.S. Surgical Robotics Market: Porter’s Five Forces Analysis
TABLE 25: U.S. Surgical Robotics Market: Surgical Robotic System Pricing Trends, 2025–2035
TABLE 26: U.S. Surgical Robotics Market: Instruments, Accessories and Service Pricing Analysis
TABLE 27: U.S. Surgical Robotics Market: Value Chain & Supply Chain Analysis
TABLE 28: U.S. Surgical Robotics Market: AI, Computer Vision and Digital Surgery Impact
TABLE 29: U.S. Surgical Robotics Market: FDA Regulatory Framework Analysis
TABLE 30: U.S. Surgical Robotics Market: CMS Reimbursement and Coverage Landscape
TABLE 31: U.S. Surgical Robotics Market: Hospital Value Analysis Committee Decision Framework
TABLE 32: U.S. Surgical Robotics Market: Robotic Platform Switching Cost and Vendor Lock-In Analysis
TABLE 33: U.S. Surgical Robotics Market: Offering Snapshot, 2025
TABLE 34: Segment Dashboard; Definition and Scope, by Offering
TABLE 35: U.S. Surgical Robotics Market, by Offering, 2021–2035 (US$ Billion)
TABLE 36: U.S. Surgical Robotics Market: Segment Share Analysis, by Offering, 2025 & 2035 (%)
TABLE 37: U.S. Surgical Robotics Market: Robotic Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 38: U.S. Surgical Robotics Market: Instruments & Accessories Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 39: U.S. Surgical Robotics Market: Software & Digital Solutions Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 40: U.S. Surgical Robotics Market: Services & Support Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 41: U.S. Surgical Robotics Market: Surgical Application Snapshot, 2025
TABLE 42: Segment Dashboard; Definition and Scope, by Surgical Application
TABLE 43: U.S. Surgical Robotics Market, by Surgical Application, 2021–2035 (US$ Billion)
TABLE 44: U.S. Surgical Robotics Market: Segment Share Analysis, by Surgical Application, 2025 & 2035 (%)
TABLE 45: U.S. Surgical Robotics Market: General Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 46: U.S. Surgical Robotics Market: Urologic Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 47: U.S. Surgical Robotics Market: Gynecologic Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 48: U.S. Surgical Robotics Market: Orthopedic Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 49: U.S. Surgical Robotics Market: Colorectal, Thoracic and Bariatric Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 50: U.S. Surgical Robotics Market: Spine, Neurosurgery, Microsurgery and Other Applications Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 51: U.S. Surgical Robotics Market: Robotic Platform Type Snapshot, 2025
TABLE 52: Segment Dashboard; Definition and Scope, by Robotic Platform Type
TABLE 53: U.S. Surgical Robotics Market, by Robotic Platform Type, 2021–2035 (US$ Billion)
TABLE 54: U.S. Surgical Robotics Market: Segment Share Analysis, by Robotic Platform Type, 2025 & 2035 (%)
TABLE 55: U.S. Surgical Robotics Market: Soft-Tissue Multiport Systems Market Size and Forecast, 2021–2035
TABLE 56: U.S. Surgical Robotics Market: Single-Port, Compact and Miniaturized Systems Market Size and Forecast, 2021–2035
TABLE 57: U.S. Surgical Robotics Market: Orthopedic Robotic Systems Market Size and Forecast, 2021–2035
TABLE 58: U.S. Surgical Robotics Market: Spine and Neurosurgical Robotic Systems Market Size and Forecast, 2021–2035
TABLE 59: U.S. Surgical Robotics Market: Microsurgery and Specialty Robotic Systems Market Size and Forecast, 2021–2035
TABLE 60: U.S. Surgical Robotics Market: End User Snapshot, 2025
TABLE 61: Segment Dashboard; Definition and Scope, by End User
TABLE 62: U.S. Surgical Robotics Market, by End User, 2021–2035 (US$ Billion)
TABLE 63: U.S. Surgical Robotics Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 64: U.S. Surgical Robotics Market: Hospitals and Integrated Health Systems Market Size and Forecast, 2021–2035
TABLE 65: U.S. Surgical Robotics Market: Academic Medical Centers Market Size and Forecast, 2021–2035
TABLE 66: U.S. Surgical Robotics Market: Specialty Surgical Hospitals Market Size and Forecast, 2021–2035
TABLE 67: U.S. Surgical Robotics Market: Ambulatory Surgery Centers Market Size and Forecast, 2021–2035
TABLE 68: U.S. Surgical Robotics Market: Other Surgical Facilities Market Size and Forecast, 2021–2035
TABLE 69: U.S. Surgical Robotics Market: Capital Cost, Service Cost and Total Cost of Ownership Analysis
TABLE 70: U.S. Surgical Robotics Market: Cost per Robotic Procedure and Break-Even Volume Analysis
TABLE 71: U.S. Surgical Robotics Market: OR Workflow, Setup and Turnover Economics
TABLE 72: U.S. Surgical Robotics Market: Capital Purchase, Lease and Usage-Based Commercial Models
TABLE 73: U.S. Surgical Robotics Market: IDN Contracting and Robotic Platform Standardization Analysis
TABLE 74: U.S. Surgical Robotics Market: ASC Robotic Surgery Business Case
TABLE 75: U.S. Surgical Robotics Market: Recurring Revenue and Installed-Base Monetization Analysis
TABLE 76: U.S. Surgical Robotics Market: Robotic Surgery ROI Framework
TABLE 77: U.S. Surgical Robotics Market: Regional Snapshot, 2025
TABLE 78: Segment Dashboard; Definition and Scope, by Geography
TABLE 79: U.S. Surgical Robotics Market, by Region, 2021–2035 (US$ Billion)
TABLE 80: U.S. Surgical Robotics Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 81: U.S. Surgical Robotics Market: Regional Installed Base and Procedure Volume Analysis
TABLE 82: West Region U.S. Surgical Robotics Market: Regional Overview, Trends and Procurement Ecosystem
TABLE 83: West Region U.S. Surgical Robotics Market, by State, 2021–2035 (US$ Billion)
TABLE 84: West Region U.S. Surgical Robotics Market, by Offering, 2021–2035 (US$ Billion)
TABLE 85: West Region U.S. Surgical Robotics Market, by Surgical Application, 2021–2035 (US$ Billion)
TABLE 86: West Region U.S. Surgical Robotics Market, by Robotic Platform Type, 2021–2035 (US$ Billion)
TABLE 87: West Region U.S. Surgical Robotics Market, by End User, 2021–2035 (US$ Billion)
TABLE 88: California Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 89: Washington Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 90: Arizona Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 91: Colorado Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 92: Oregon Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 93: Utah Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 94: Nevada Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 95: New Mexico Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 96: Idaho Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 97: Montana Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 98: Wyoming Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 99: Alaska Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 100: Hawaii Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 101: Northeast Region U.S. Surgical Robotics Market: Regional Overview, Trends and Procurement Ecosystem
TABLE 102: Northeast Region U.S. Surgical Robotics Market, by State, 2021–2035 (US$ Billion)
TABLE 103: Northeast Region U.S. Surgical Robotics Market, by Offering, 2021–2035 (US$ Billion)
TABLE 104: Northeast Region U.S. Surgical Robotics Market, by Surgical Application, 2021–2035 (US$ Billion)
TABLE 105: Northeast Region U.S. Surgical Robotics Market, by Robotic Platform Type, 2021–2035 (US$ Billion)
TABLE 106: Northeast Region U.S. Surgical Robotics Market, by End User, 2021–2035 (US$ Billion)
TABLE 107: New York Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 108: Massachusetts Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 109: New Jersey Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 110: Pennsylvania Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 111: Connecticut Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 112: Maine Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 113: Vermont Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 114: New Hampshire Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 115: Rhode Island Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 116: Delaware Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 117: South Region U.S. Surgical Robotics Market: Regional Overview, Trends and Procurement Ecosystem
TABLE 118: South Region U.S. Surgical Robotics Market, by State, 2021–2035 (US$ Billion)
TABLE 119: South Region U.S. Surgical Robotics Market, by Offering, 2021–2035 (US$ Billion)
TABLE 120: South Region U.S. Surgical Robotics Market, by Surgical Application, 2021–2035 (US$ Billion)
TABLE 121: South Region U.S. Surgical Robotics Market, by Robotic Platform Type, 2021–2035 (US$ Billion)
TABLE 122: South Region U.S. Surgical Robotics Market, by End User, 2021–2035 (US$ Billion)
TABLE 123: Texas Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 124: Florida Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 125: Georgia Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 126: North Carolina Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 127: Tennessee Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 128: South Carolina Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 129: Alabama Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 130: Mississippi Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 131: Louisiana Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 132: Arkansas Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 133: Kentucky Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 134: Oklahoma Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 135: Virginia Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 136: Maryland Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 137: West Virginia Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 138: Midwest Region U.S. Surgical Robotics Market: Regional Overview, Trends and Procurement Ecosystem
TABLE 139: Midwest Region U.S. Surgical Robotics Market, by State, 2021–2035 (US$ Billion)
TABLE 140: Midwest Region U.S. Surgical Robotics Market, by Offering, 2021–2035 (US$ Billion)
TABLE 141: Midwest Region U.S. Surgical Robotics Market, by Surgical Application, 2021–2035 (US$ Billion)
TABLE 142: Midwest Region U.S. Surgical Robotics Market, by Robotic Platform Type, 2021–2035 (US$ Billion)
TABLE 143: Midwest Region U.S. Surgical Robotics Market, by End User, 2021–2035 (US$ Billion)
TABLE 144: Illinois Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 145: Ohio Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 146: Michigan Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 147: Minnesota Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 148: Indiana Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 149: Wisconsin Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 150: Missouri Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 151: Iowa Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 152: Kansas Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 153: Nebraska Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 154: North Dakota Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 155: South Dakota Surgical Robotics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 156: U.S. Surgical Robotics Market: Competitive Landscape Snapshot, 2025
TABLE 157: U.S. Surgical Robotics Market: Key Company Market Share Analysis, 2025
TABLE 158: U.S. Surgical Robotics Market: Company Positioning Matrix
TABLE 159: U.S. Surgical Robotics Market: Surgical Robotic Platform Benchmarking
TABLE 160: U.S. Surgical Robotics Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 161: Intuitive Surgical: Company Profile
TABLE 162: Stryker Corporation: Company Profile
TABLE 163: Medtronic: Company Profile
TABLE 164: Johnson & Johnson MedTech: Company Profile
TABLE 165: Zimmer Biomet: Company Profile
TABLE 166: Smith+Nephew: Company Profile
TABLE 167: Globus Medical: Company Profile
TABLE 168: CMR Surgical: Company Profile
TABLE 169: Distalmotion: Company Profile
TABLE 170: Virtual Incision: Company Profile
TABLE 171: Medical Microinstruments (MMI): Company Profile
TABLE 172: Moon Surgical: Company Profile
TABLE 173: THINK Surgical: Company Profile
TABLE 174: PROCEPT BioRobotics: Company Profile
TABLE 175: Brainlab: Company Profile
TABLE 176: Accuray: Company Profile
TABLE 177: KARL STORZ / Asensus Surgical: Company Profile
TABLE 178: Renishaw: Company Profile
TABLE 179: Vicarious Surgical: Company Profile
TABLE 180: EndoQuest Robotics: Company Profile
TABLE 181: SS Innovations International: Company Profile
TABLE 182: Momentis Surgical: Company Profile
TABLE 183: Quantum Surgical: Company Profile
TABLE 184: Microbot Medical: Company Profile
TABLE 185: Levita Magnetics: Company Profile
TABLE 186: U.S. Surgical Robotics Market: Future Market Scenario Analysis, 2026–2035
TABLE 187: U.S. Surgical Robotics Market: Disruptive Technologies Impact Matrix
TABLE 188: U.S. Surgical Robotics Market: Future Robotic Procedure Penetration Analysis
TABLE 189: U.S. Surgical Robotics Market: Robotic System Replacement Cycle Outlook
TABLE 190: U.S. Surgical Robotics Market: ASC Adoption Opportunity, 2026–2035
TABLE 191: U.S. Surgical Robotics Market: Emerging Business and Commercial Models
TABLE 192: U.S. Surgical Robotics Market: Investment Prioritization Matrix
TABLE 193: U.S. Surgical Robotics Market: Technology White-Space Analysis
TABLE 194: U.S. Surgical Robotics Market: Strategic Recommendations for Surgical Robotics Manufacturers
TABLE 195: U.S. Surgical Robotics Market: Strategic Recommendations for Hospitals and Integrated Health Systems
TABLE 196: U.S. Surgical Robotics Market: Strategic Recommendations for Ambulatory Surgery Centers
TABLE 197: U.S. Surgical Robotics Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 198: U.S. Surgical Robotics Market: Strategic Recommendations for New Entrants and Startups
TABLE 199: U.S. Surgical Robotics Market: Go-to-Market and Hospital IDN Penetration Strategy
TABLE 200: U.S. Surgical Robotics Market: Pricing, Contracting and Installed-Base Expansion Strategy
TABLE 201: U.S. Surgical Robotics Market: Product Positioning and Portfolio Expansion Guidance
TABLE 202: U.S. Surgical Robotics Market: Scope Limitation
TABLE 203: U.S. Surgical Robotics Market: Data Use Limitation
TABLE 204: U.S. Surgical Robotics Market: Forecasting Limitation
TABLE 205: U.S. Surgical Robotics Market: Legal Disclaimer
TABLE 206: U.S. Surgical Robotics Market: Third-Party Data Disclaimer
TABLE 207: U.S. Surgical Robotics Market: Company, Product and Regulatory Status Disclaimer

List of Figures

FIGURE 1: U.S. Surgical Robotics Market Segmentation
FIGURE 2: U.S. Surgical Robotics Market Research Methodology
FIGURE 3: U.S. Surgical Robotics Market Ecosystem
FIGURE 4: U.S. Surgical Robotics Market Stakeholder Framework
FIGURE 5: U.S. Surgical Robotics Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 6: U.S. Surgical Robotics Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 7: U.S. Surgical Robotics Market Year-wise Growth Curve, 2021–2035
FIGURE 8: U.S. Surgical Robotics Installed Base and Robotic Procedure Volume Trend
FIGURE 9: U.S. Surgical Robotics Market Attractiveness Analysis
FIGURE 10: U.S. Surgical Robotics Market Dynamics
FIGURE 11: Surgical Robotics Innovation & Patent Landscape, 2021–2025
FIGURE 12: Robotic Procedure Workflow Economics Framework
FIGURE 13: Hospital Capital Procurement Decision Framework
FIGURE 14: Installed Base Utilization and Procedure Conversion Framework
FIGURE 15: U.S. Surgical Robotics Market PESTEL Analysis
FIGURE 16: U.S. Surgical Robotics Market Porter’s Five Forces Analysis
FIGURE 17: Surgical Robotics Value Chain Analysis
FIGURE 18: Surgical Robotics Supply Chain Analysis
FIGURE 19: AI, Computer Vision and Digital Surgery Impact Framework
FIGURE 20: FDA Regulatory and CMS Reimbursement Framework
FIGURE 21: Offering Segment Market Share Analysis, 2025 & 2035
FIGURE 22: Offering Segment Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 23: Robotic Systems Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 24: Instruments & Accessories Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 25: Software, Digital Solutions and Services Growth Analysis, 2021–2035
FIGURE 26: Surgical Application Segment Market Share Analysis, 2025 & 2035
FIGURE 27: Surgical Application Segment Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 28: General Surgery Robotic Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 29: Urologic Surgery Robotic Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 30: Orthopedic Surgery Robotic Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 31: Gynecologic, Colorectal, Thoracic and Bariatric Robotics Growth Analysis
FIGURE 32: Spine, Neurosurgery and Microsurgery Robotics Opportunity Analysis
FIGURE 33: Robotic Platform Type Segment Market Share Analysis, 2025 & 2035
FIGURE 34: Robotic Platform Type Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 35: Soft-Tissue Multiport Robotic Systems Growth Analysis
FIGURE 36: Compact, Miniaturized and Single-Port Robotics Growth Analysis
FIGURE 37: Orthopedic Surgical Robotics Growth Analysis
FIGURE 38: Spine, Neurosurgery and Specialty Robotic Platform Growth Analysis
FIGURE 39: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 40: End User Segment Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 41: Hospitals and Integrated Health Systems Robotics Adoption Trend
FIGURE 42: Academic and Specialty Surgical Hospital Robotics Adoption Trend
FIGURE 43: Ambulatory Surgery Center Robotics Growth Opportunity, 2021–2035
FIGURE 44: Surgical Robotic System Total Cost of Ownership Framework
FIGURE 45: Robotic Procedure Break-Even Volume Analysis
FIGURE 46: Capital Purchase vs. Lease vs. Usage-Based Commercial Model
FIGURE 47: Robotic Platform Standardization and IDN Contracting Framework
FIGURE 48: ASC Robotic Surgery Business Case
FIGURE 49: Installed-Base Recurring Revenue Model
FIGURE 50: U.S. Surgical Robotics Market Regional Share Analysis, 2025 & 2035
FIGURE 51: U.S. Surgical Robotics Market Regional Size Forecast and Trend Analysis, 2021–2035
FIGURE 52: U.S. Surgical Robotics Regional Installed Base and Procedure Volume Analysis
FIGURE 53: West Region U.S. Surgical Robotics Market Share and Leading Players, 2025
FIGURE 54: West Region Market Share Analysis by State, 2025
FIGURE 55: West Region Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 56: California Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 57: Washington Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 58: Arizona Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 59: Colorado Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 60: Oregon Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 61: Utah Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 62: Nevada Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 63: New Mexico Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 64: Idaho Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 65: Montana Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 66: Wyoming Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 67: Alaska Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 68: Hawaii Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 69: Northeast Region U.S. Surgical Robotics Market Share and Leading Players, 2025
FIGURE 70: Northeast Region Market Share Analysis by State, 2025
FIGURE 71: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 72: New York Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 73: Massachusetts Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 74: New Jersey Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 75: Pennsylvania Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 76: Connecticut Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 77: Maine Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 78: Vermont Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 79: New Hampshire Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 80: Rhode Island Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 81: Delaware Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 82: South Region U.S. Surgical Robotics Market Share and Leading Players, 2025
FIGURE 83: South Region Market Share Analysis by State, 2025
FIGURE 84: South Region Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 85: Texas Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 86: Florida Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 87: Georgia Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 88: North Carolina Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 89: Tennessee Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 90: South Carolina Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 91: Alabama Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 92: Mississippi Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 93: Louisiana Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 94: Arkansas Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 95: Kentucky Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 96: Oklahoma Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 97: Virginia Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 98: Maryland Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 99: West Virginia Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 100: Midwest Region U.S. Surgical Robotics Market Share and Leading Players, 2025
FIGURE 101: Midwest Region Market Share Analysis by State, 2025
FIGURE 102: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 103: Illinois Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 104: Ohio Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 105: Michigan Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 106: Minnesota Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 107: Indiana Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 108: Wisconsin Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 109: Missouri Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 110: Iowa Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 111: Kansas Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 112: Nebraska Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 113: North Dakota Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 114: South Dakota Surgical Robotics Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 115: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 116: Surgical Robotics Company Positioning Matrix
FIGURE 117: Key Surgical Robotic Platform Benchmarking
FIGURE 118: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 119: U.S. Surgical Robotics Innovation Roadmap
FIGURE 120: Soft-Tissue Surgical Robotics Competitive Evolution
FIGURE 121: Orthopedic Surgical Robotics Opportunity Roadmap
FIGURE 122: Compact and Specialty Surgical Robotics Adoption Roadmap
FIGURE 123: Future Market Scenario Analysis, 2026–2035
FIGURE 124: Disruptive Surgical Robotics Technologies Impact Matrix
FIGURE 125: Future Robotic Procedure Penetration Roadmap
FIGURE 126: Surgical Robotic System Replacement Cycle Outlook
FIGURE 127: ASC Surgical Robotics Adoption Roadmap
FIGURE 128: Investment Prioritization Matrix
FIGURE 129: Surgical Robotics Technology White-Space Map
FIGURE 130: Strategic Growth Roadmap for U.S. Surgical Robotics Companies
FIGURE 131: Hospital and IDN Go-to-Market Strategy Framework
FIGURE 132: ASC Commercialization Strategy Framework
FIGURE 133: Installed-Base Expansion and Recurring Revenue Strategy
FIGURE 134: Product Positioning and Portfolio Expansion Framework
FIGURE 135: Report Scope and Disclaimer Framework